Hannes Lengauer

Title: Hannes Lengauer: Innovator in Pharmaceutical Chemistry

Introduction

Hannes Lengauer is a notable inventor based in Kundl, Austria, recognized for his contributions to pharmaceutical chemistry. With a total of six patents to his name, he has made significant advancements in the development of innovative pharmaceutical compositions.

Latest Patents

Among his latest patents is the invention of a co-crystal of an orally available HIF prolyl hydroxylase inhibitor. This invention relates to a co-crystal of roxadustat with L-proline and outlines a process for its preparation. The pharmaceutical composition derived from this co-crystal can be utilized as a medicament, particularly for the treatment and prevention of anemia in patients suffering from end-stage renal disease (ESRD) and chronic kidney disease (CKD). Another significant patent is for crystalline eravacycline bis-hydrochloride, which includes a process for its preparation and its use in pharmaceutical compositions. This invention is particularly relevant for treating bacterial infections caused by multidrug-resistant Gram-negative pathogens.

Career Highlights

Hannes has worked with Sandoz AG, where he contributed to various pharmaceutical innovations. His work has been instrumental in advancing the field of medicinal chemistry, particularly in developing effective treatments for serious health conditions.

Collaborations

Hannes has collaborated with notable professionals in the field, including Andreas Hotter and Verena Adamer. These collaborations have further enriched his research and development efforts.

Conclusion

Hannes Lengauer's innovative work in pharmaceutical chemistry has led to significant advancements in the treatment of critical health issues. His contributions continue to impact the medical field positively.